DEFECTS IN CAVEOLIN-1 CAUSES DILATED CARDIOMYOPATHY AND PULMONARY HYPERTENSION IN KNOCKOUT MICE

被引：0
|
作者：
Chu, Pao-Hsien [1 ]
Chien, Kenneth R. [2 ,3 ]
机构：
[1] Chang Gung Mem Hosp, Dept Internal Med, Cardiovasc Div, Taoyuan, Taiwan
[2] UCSD, Salk Program Mol Med, La Jolla, CA USA
[3] UCSD, Inst Mol Med, La Jolla, CA USA
来源：
INTERNATIONAL JOURNAL OF CARDIOLOGY | 2004年 / 97卷
关键词：
D O I：
10.1016/S0167-5273(04)80036-6
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
S7-03
引用
收藏
页码：S12 / S12
页数：1
相关论文
共 50 条
  • [41] Pulmonary hypertension and metabolic syndrome: Possible connection, PPAR. and Caveolin-1
    Mathew, Rajamma
    WORLD JOURNAL OF CARDIOLOGY, 2014, 6 (08): : 692 - 705
  • [42] Caveolin-1: a critical regulator of pulmonary vascular architecture and nitric oxide bioavailability in pulmonary hypertension
    Ryter, Stefan W.
    Choi, Augustine M. K.
    AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2008, 294 (05) : L862 - L864
  • [43] The Cavin-1/Caveolin-1 interaction attenuates BMP/Smad signaling in pulmonary hypertension by interfering with BMPR2/Caveolin-1 binding
    Tomita, Shinya
    Nakanishi, Naohiko
    Ogata, Takehiro
    Higuchi, Yusuke
    Sakamoto, Akira
    Tsuji, Yumika
    Suga, Takaomi
    Matoba, Satoaki
    COMMUNICATIONS BIOLOGY, 2024, 7 (01)
  • [44] The Cavin-1/Caveolin-1 interaction attenuates BMP/Smad signaling in pulmonary hypertension by interfering with BMPR2/Caveolin-1 binding
    Shinya Tomita
    Naohiko Nakanishi
    Takehiro Ogata
    Yusuke Higuchi
    Akira Sakamoto
    Yumika Tsuji
    Takaomi Suga
    Satoaki Matoba
    Communications Biology, 7
  • [45] Clinical characteristics of dilated cardiomyopathy with pulmonary hypertension
    Han, Bing
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2018, 11 (08): : 8566 - 8575
  • [46] A predictive model for dilated cardiomyopathy with pulmonary hypertension
    Liang, Jiahua
    Zhu, Ruochen
    Yang, Yi
    Li, Rong
    Hong, Chuangxiong
    Luo, Chuanjin
    ESC HEART FAILURE, 2021, 8 (05): : 4255 - 4264
  • [47] Cardiac function is not significantly diminished in hearts isolated from young caveolin-1 knockout mice
    Chow, Ava K.
    Daniel, Edwin E.
    Schulz, Richard
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2010, 299 (04): : H1183 - H1189
  • [48] ALTERATIONS IN LIVER CAVEOLIN-1 EXPRESSION ON LIPIDS AND ATHEROSCLEROSIS DEVELOPMENT IN APOE-KNOCKOUT MICE
    Zurkinden, L.
    Monsour, Y. T.
    Rohrbach, B.
    Vogt, B.
    Mistry, H. D.
    Escher, G.
    ATHEROSCLEROSIS, 2015, 241 (01) : E94 - E94
  • [49] Persistent eNOS activation secondary to caveolin-1 deficiency induces pulmonary hypertension in mice and humans through PKG nitration
    Zhao, You-Yang
    Zhao, Yidan D.
    Mirza, Muhammad K.
    Huang, Julia H.
    Potula, Hari-Hara S. K.
    Vogel, Steven M.
    Brovkovych, Viktor
    Yuan, Jason X. -J.
    Wharton, John
    Malik, Asrar B.
    JOURNAL OF CLINICAL INVESTIGATION, 2009, 119 (07): : 2009 - 2018
  • [50] Expression of a Human Caveolin-1 Mutation in Mice Drives Inflammatory and Metabolic Defect-Associated Pulmonary Arterial Hypertension
    Rathinasabapathy, Anandharajan
    Copeland, Courtney
    Crabtree, Amber
    Carrier, Erica J.
    Moore, Christy
    Shay, Sheila
    Gladson, Santhi
    Austin, Eric D.
    Kenworthy, Anne K.
    Loyd, James E.
    Hemnes, Anna R.
    West, James D.
    FRONTIERS IN MEDICINE, 2020, 7
12345